• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病的内分泌机制:雄激素受体的表达与降解:机制及临床意义

Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication.

作者信息

Lee Dong Kun, Chang Chawnshang

机构信息

George Whipple Laboratory for Cancer Research, Department of Pathology, and Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA.

出版信息

J Clin Endocrinol Metab. 2003 Sep;88(9):4043-54. doi: 10.1210/jc.2003-030261.

DOI:10.1210/jc.2003-030261
PMID:12970260
Abstract

The androgen-androgen receptor (AR) signaling pathway plays a key role in proper development and function of male reproductive organs, such as prostate and epididymis, as well as nonreproductive organs, such as muscle, hair follicles, and brain. Abnormalities in the androgen-AR signaling pathway have been linked to diseases, such as male infertility, Kennedy's disease, and prostate cancer. Regulation of AR activity can be achieved in several different ways: modulation of AR gene expression, androgen binding to AR, AR nuclear translocation, AR protein stability, and AR trans-activation. This review covers mechanisms implicated in the control of AR protein expression and degradation, and their potential linkage to the androgen-related diseases. A better understanding of such mechanisms may help us to design more effective androgens and antiandrogens to battle androgen-related diseases.

摘要

雄激素-雄激素受体(AR)信号通路在男性生殖器官(如前列腺和附睾)以及非生殖器官(如肌肉、毛囊和大脑)的正常发育和功能中起着关键作用。雄激素-AR信号通路的异常与男性不育、肯尼迪病和前列腺癌等疾病有关。AR活性的调节可以通过几种不同的方式实现:AR基因表达的调节、雄激素与AR的结合、AR的核转位、AR蛋白的稳定性以及AR的反式激活。本综述涵盖了与AR蛋白表达和降解控制相关的机制,以及它们与雄激素相关疾病的潜在联系。更好地理解这些机制可能有助于我们设计更有效的雄激素和抗雄激素药物来对抗雄激素相关疾病。

相似文献

1
Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication.疾病的内分泌机制:雄激素受体的表达与降解:机制及临床意义
J Clin Endocrinol Metab. 2003 Sep;88(9):4043-54. doi: 10.1210/jc.2003-030261.
2
The contribution of different androgen receptor domains to receptor dimerization and signaling.不同雄激素受体结构域对受体二聚化和信号传导的作用。
Mol Endocrinol. 2008 Nov;22(11):2373-82. doi: 10.1210/me.2008-0017. Epub 2008 Jul 10.
3
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.
4
[The androgen receptor: molecular pathology].[雄激素受体:分子病理学]
J Soc Biol. 2002;196(3):223-40.
5
Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.雄激素受体过度激活会导致前列腺癌细胞的雄激素非依赖性生长。
J Mol Endocrinol. 2008 Jul;41(1):13-23. doi: 10.1677/JME-07-0158. Epub 2008 May 9.
6
Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens.全细胞中雄激素受体的脱氧核糖核酸结合能力:对雄激素和抗雄激素作用的影响。
Endocrinology. 1996 May;137(5):1870-7. doi: 10.1210/endo.137.5.8612526.
7
Collocation of androgen receptor gene mutations in prostate cancer.前列腺癌中雄激素受体基因突变的搭配
Clin Cancer Res. 2001 May;7(5):1273-81.
8
Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.雄激素受体在不同治疗性抗雄激素的作用下靶向不同的亚细胞区室。
Clin Cancer Res. 2004 Nov 1;10(21):7392-401. doi: 10.1158/1078-0432.CCR-04-0388.
9
Androgen receptor in prostate cancer.前列腺癌中的雄激素受体。
Endocr Rev. 2004 Apr;25(2):276-308. doi: 10.1210/er.2002-0032.
10
Pleiotropic functional properties of androgen receptor mutants in prostate cancer.雄激素受体突变体在前列腺癌中的多效性功能特性
Hum Mutat. 2009 Feb;30(2):145-57. doi: 10.1002/humu.20848.

引用本文的文献

1
PROTAC technology for prostate cancer treatment.用于前列腺癌治疗的PROTAC技术。
Acta Mater Med. 2025 Jan 7;4(1):99-121. doi: 10.15212/amm-2024-0075. Epub 2025 Jan 30.
2
Alpha Thalassemia/Intellectual Disability Syndrome X-Linked Expression Varies Significantly between Androgen Receptor-Positive and Androgen Receptor-Negative Prostatic Adenocarcinoma: Relation to Epidermal Growth Factor Receptor Expression and Clinicopathological Factors.α地中海贫血/智力残疾综合征X连锁在雄激素受体阳性和雄激素受体阴性前列腺腺癌之间的表达差异显著:与表皮生长因子受体表达及临床病理因素的关系
J Microsc Ultrastruct. 2023 Mar 22;13(2):57-67. doi: 10.4103/jmau.jmau_119_22. eCollection 2025 Apr-Jun.
3
Oxyresveratrol enhances hair regeneration in human dermal papilla cell and androgenetic alopecia mouse model.
氧化白藜芦醇可促进人毛乳头细胞和雄激素性脱发小鼠模型中的毛发再生。
Sci Rep. 2025 May 20;15(1):17551. doi: 10.1038/s41598-025-02581-z.
4
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities.非前列腺恶性肿瘤中的雄激素受体信号传导:挑战与机遇
Nat Rev Cancer. 2025 Feb;25(2):93-108. doi: 10.1038/s41568-024-00772-w. Epub 2024 Nov 25.
5
The impact of androgen-induced translation in modulating androgen receptor activity.雄激素诱导的翻译对雄激素受体活性的调节作用。
Biol Direct. 2024 Nov 11;19(1):111. doi: 10.1186/s13062-024-00550-6.
6
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.由NF-κB和p38丝裂原活化蛋白激酶信号介导的前列腺癌基质中的雄激素受体缺失会破坏基质形态发生素的产生。
Oncogene. 2024 Jun;43(27):2092-2103. doi: 10.1038/s41388-024-03064-7. Epub 2024 May 20.
7
Breaking Bad Proteins-Discovery Approaches and the Road to Clinic for Degraders.破坏坏蛋白——降解剂的发现途径与走向临床。
Cells. 2024 Mar 26;13(7):578. doi: 10.3390/cells13070578.
8
Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice.曼扎明A通过阻断E2F8与DNA的相互作用来降低雄激素受体的转录和合成,并有效抑制小鼠前列腺肿瘤的生长。
Mol Oncol. 2024 Aug;18(8):1966-1979. doi: 10.1002/1878-0261.13637. Epub 2024 Apr 11.
9
Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer.去势抵抗性前列腺癌中雄激素受体降解的最新进展洞察
Cancers (Basel). 2024 Feb 4;16(3):663. doi: 10.3390/cancers16030663.
10
Molecular Atlas of HER2+ Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance.用内源性配体处理的HER2+乳腺癌细胞分子图谱:对曲妥珠单抗耐药机制的时间洞察
Cancers (Basel). 2024 Jan 27;16(3):553. doi: 10.3390/cancers16030553.